Search Results - "Iznardo, H."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Real‐world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis by Iznardo, H., Vilarrasa, E., López‐Ferrer, A., Puig, L.

    Published in British journal of dermatology (1951) (01-09-2021)
    “…Guselkumab is an IL-23 inhibitor approved for moderate-to-severe plaque psoriasis that has demonstrated safety and efficacy in phase III clinical trials …”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Lentigo Maligna: Clinical Presentation and Appropriate Management by Iznardo, Helena, Garcia-Melendo, Cristina, Yelamos, Oriol

    “…Lentigo maligna (LM) is a type of melanoma in situ that has distinctive characteristics regarding epidemiology, risk factors and clinical features. In…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12